GSK plc (GSK)

GSK plc (GSK) is a healthcare company (drug manufacturers - general) based in the United Kingdom. The share price is $49.48, down 1.84% on the day, which values the company at $99.18B. Price as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance.

Key facts

Share price
$49.48−1.84% today
Market value
$99.18B
P/E ratio
17.2×last 12 months
Forward P/E
10.0×
Dividend yield
1.37%
Funk Score
73/100
200-week average
$41.7818% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

GSK plc in more detail

GSK trades at 17.2× its last twelve months' earnings, 10.0× next year's expected earnings, 3.0× sales. It sits 18% above its 200-week average of $41.78.

Its Funk Score is 73 out of 100 (financial strength 7.2, profitability 8.3, growth 6.4, each out of 10).

In its favour: Strong Piotroski score; High return on invested capital.

11 of the superinvestors tracked here hold GSK, including Dodge & Cox team (1.1% of the portfolio), Thomas Kahn (0.9% of the portfolio), Primecap team (0.8% of the portfolio).

Superinvestors holding GSK

11 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:GSK vs HCA (GSK plc vs HCA Healthcare)GSK vs CVS (GSK plc vs CVS Health)GSK vs MRNA (GSK plc vs Moderna)GSK vs REGN (GSK plc vs Regeneron Pharmaceuticals)GSK vs SNY (GSK plc vs Sanofi)

All health care companies by market valueLargest companies in the United KingdomAll stocks A–Z

GSK plc (GSK): questions and answers

What is GSK's P/E ratio?

GSK plc trades at 17.2× its last twelve months' earnings and 10.0× next year's expected earnings.

What is GSK's PEG ratio?

GSK plc's PEG ratio is 6.47 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is GSK plc's market cap?

GSK plc is valued at $99.18B at a share price of $49.48.

Is GSK above its 200-week moving average?

Yes. GSK is 18.4% above its 200-week average of $41.78. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is GSK plc growing?

Over the last three fiscal years GSK plc's revenue grew 3.7% a year and its earnings per share -27.6% a year.

Does GSK pay a dividend?

Yes. GSK plc's dividend yield is 1.37%, or $1.83 a share a year, paying out 63% of earnings.

Cite this page

Funkfolio, “GSK plc (GSK) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/GSK

Underlying data: Yahoo Finance; company filings with the SEC.